Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Plasmablastic Lymphoma: Experience from a Single Referral Center in Mexico

Lena Grissel Simental Legarda, Humberto Baldemar Castellanos Sinco, Alonso Hernandez, Josheline Goretti Ramirez Jaramillo, Gerardo Santigo Jimenez, Karen Yanel Eduardo Vázquez, Mariana Guízar, Juan Francisco Zazueta Pozos, Gilberto Israel Barranco Lampon, Adán Germán Gallardo-Rodríguez, Daniela De Jesus Perez Samano, Carlos Martínez Murillo, Jorge Luis García Solache, Zaira Karina Pacheco Martínez, Raquel Pacheco López, Luis Mario Villela Martinez

Blood (2024) 144 (Supplement 1): 6444.

https://doi.org/10.1182/blood-2024-206046

Published: 2024

Journal Articles

Interobserver Variability with the Diagnosis of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) ¿Is the Threshold of 20% Bone Marrow Blasts Reproducible?

Blood (2021) 138 (Supplement 1): 2607.

https://doi.org/10.1182/blood-2021-149147

Published: 2021

Journal Articles

The Elevation of LIVER Enzymes in Patients with Atrial Fibrillation and COVID-19 Is a Marker of Bad Evolution and Mortality

Juan Jose Cerezo Manchado, MDPhD, Pável E Olivera, MD, María Dolores Lopez Abellan, Desiree Campoy Castaño, César A Velasquez, MD, Carlos Rodriguez Rojas, Veronica Ramos Arenas, Katia Flores, MD, Rubén Cárdenas Gámez, Luis García de Guadiana Romualdo, PhD, Teodoro Iturbe Hernandez, Jorge Sierra, MD, Ramón Salinas, MD PhD

Blood (2020) 136 (Supplement 1): 14–15.

https://doi.org/10.1182/blood-2020-142451

Published: 2020

Journal Articles

Blood monitoring of circulating tumor plasma cells by next generation flow in multiple myeloma after therapy

Blood (2019) 134 (24): 2218–2222.

https://doi.org/10.1182/blood.2019002610

Published: 2019

Includes: Supplemental data

Journal Articles

Altered Immunophenotypes on Leukemic and/or Monocytic Cells from Acute Myeloid Leukemia Highly Predict for Nucleophosmin Gene Mutation

Blood (2019) 134 (Supplement_1): 2687.

https://doi.org/10.1182/blood-2019-131733

Published: 2019

Journal Articles

CRISPR/Cas9-Generated Models Uncover Therapeutic Vulnerabilities of Del(11q) Chronic Lymphocytic Leukemia Cells to Dual BCR and PARP Inhibition

Miguel Quijada Álamo, BSc, MSc, María Hernández-Sánchez, PhD, José Luis Ordóñez, PhD, Verónica Alonso Pérez, PhD, Ana E. Rodriguez, PhD, Ignacio García-Tuñón, PhD, Ana B Herrero, PhD, Laura San-Segundo, Michaela Gruber, MD PhD, Juan Luis García, PhD, Rocio Benito, PhD, Catherine J. Wu, MD, Jesús-María Hernández-Rivas, MD PhD

Blood (2018) 132 (Supplement 1): 948.

https://doi.org/10.1182/blood-2018-99-116080

Published: 2018

Journal Articles

Multiparametric Flow Fytometry Is More Useful Than Cytology As a Diagnostic Tool for Endoscopic and Transbronchial Ultrasound-Guided Fine Needle Aspiration Samples in Hematological Malignancies: A Single Center Experience

Luis García, José A. Calvo, Mya Hae Tha, MRCP, Oscar Blanco, Antonio Velasco, Rosa Cordovilla, Noemi Puig, MD PhD, Alejandro Martín, MD PhD, Oscar Ferre, Felix López, Nerea Arratibel, Mónica Baile, MD, Alvaro Veiga, Javier Carrillo, Alejandro Avendaño, Daniel Rivera, Consuelo Del Cañizo, MD PhD, Belen Vidriales, MD

Blood (2016) 128 (22): 3039.

https://doi.org/10.1182/blood.V128.22.3039.3039

Published: 2016

Journal Articles

Sustained Overall Survival Benefit with Lenalidomide Plus Dexamethasone Versus No Treatment in Patients with Smoldering Myeloma at High Risk of Progression to Myeloma: Long Term Analysis

Maria-Victoria Mateos, MD PhD, Miguel-T Hernandez, Pilar Giraldo, MD PhD, Javier De La Rubia, Felipe De Arriba, Lucia Lopez-Corral, Laura Rosiñol, Bruno Paiva, PhD, Luis Palomera, MD PhD, Joan Bargay, MD, Albert Oriol, Felipe Prosper, MD, Javier Lopez, Sr., MD PhD, Jose-María Arguiñano, Nuria Quintana, Jose Luis Garcia, Joan Bladé, Juan José Lahuerta, MD PhD, Jesus San Miguel, MD PhD

Blood (2016) 128 (22): 3308.

https://doi.org/10.1182/blood.V128.22.3308.3308

Published: 2016

Journal Articles

Hemorrhagic Cystitis in Haploidentical Hematopoietic STEM CELL Trasplant: Retrospective Study and Comparison with a NON-Haploidentical DONOR Transplant Group

Nerea Arratibel, Monica Cabrero, Estefania Perez, Oriana Lopez, Lucia Lopez, Ana A. Martin, Alvaro Veiga, Monica Baile, Veronica Gonzalez, Felix Lopez, Oscar Ferre, Luis García, Dolores Caballero, MD PhD, Lourdes Vazquez, MD, Maria-Victoria Mateos, MD PhD

Blood (2016) 128 (22): 3418.

https://doi.org/10.1182/blood.V128.22.3418.3418

Published: 2016

Journal Articles

Immunoglobulin Heavy/Light Chain Ratio and Suppression of the Myeloma Non-Involved Heavy/Light Chain Pair Isotype Correlate with Poor Survival in Multiple Myeloma at Diagnosis and after Autologous Stem Cell Transplant

José Luís García de Veas Silva, Nuno Barbosa, Rafael Rios Tamayo, Carmen Bermudo Guitarte, Tiago M Pais, PhD, Teresa Rodríguez Ruiz

Blood (2016) 128 (22): 5647.

https://doi.org/10.1182/blood.V128.22.5647.5647

Published: 2016

Journal Articles

Prognostic Impact, Phenotypic and Molecular Characterization of Concordant and Discordant Bone Marrow Involvement in Patients with Diffuse Large b-Cell Lymphoma

Sara Alonso, MD, Miguel Alcoceba, Oscar Blanco, Julio Davila, MD, Juan Carlos Caballero, MD, Luis Garcia, Oscar Ferre, Felix Lopez-Cadenas, Nerea Arratibel, Alvaro Veiga, Monica Baile, Oriana Lopez, Estefania Perez, Maria Dolores Caballero, MD PhD, Marcos González, MD PhD, Consuelo Del Cañizo, MD PhD, Maria Belen Vidriales, MD PhD, Alejandro Martin, MD PhD

Blood (2015) 126 (23): 3871.

https://doi.org/10.1182/blood.V126.23.3871.3871

Published: 2015

Journal Articles

Multiple Myeloma with Prior Precursor Disease Shows Better Outcome

Rafael Ríos-Tamayo, MD, Juan Sáinz Pérez, Manuel Jurado, MD, Jose Manuel Puerta Puerta, MD, Pedro Antonio González Sierra, MD, Antonio Romero Aguilar, MD, Elisa Lopez Fernandez, MD, Lucia Moratalla Lopez, MD, José Luís García de Veas Silva, Teresa Rodríguez Ruiz, José Juan Jiménez Moleón, MD, María José Sánchez Pérez, MD

Blood (2015) 126 (23): 1756.

https://doi.org/10.1182/blood.V126.23.1756.1756

Published: 2015

Journal Articles

A New Model for Risk Stratification in Patients with Newly Diagnosed Multiple Myeloma: Impact of Serum Free Light Chains in Prognosis

José Luís García de Veas Silva, Johanna Carolina Rojas Novoa, Carmen Bermudo Guitarte, Stephen Harding, PhD, Luisa Campos, Rafael Duro Millan

Blood (2015) 126 (23): 5338.

https://doi.org/10.1182/blood.V126.23.5338.5338

Published: 2015

Journal Articles

Long Term Follow-up on the Tretament of High Risk Smoldering Myeloma with Lenalidomide Plus Low Dose Dex (Rd) (phase III spanish trial): Persistent Benefit in Overall Survival

Maria-Victoria Mateos, MD PhD, Miguel T Hernandez, MD, Pilar Giraldo, MD PhD, Javier De La Rubia, Felipe de Arriba, Lucía López-Corral, MD PhD, Laura Rosiñol, MD PhD, Bruno Paiva, PhD, Luis Palomera, Joan Bargay, MD, Albert Oriol, MD, Felipe Prosper, MD, Javier López, Eduardo Olavarría, MD, Nuria Quintana, Jose Luis García, Joan Blade, Juan José Lahuerta, MD PhD, Jesus F. San Miguel

Blood (2014) 124 (21): 3465.

https://doi.org/10.1182/blood.V124.21.3465.3465

Published: 2014

Journal Articles

Post-Transcriptional Modifications Explain the Overexpression of CCND2 in Multiple Myeloma

Irena Misiewicz-Krzeminska, PhD, Maria Eugenia Sarasquete, PhD, Carolina Vicente-Dueñas, PhD, Patryk Krzeminski, PhD, Katarzyna Wiktorska, PhD, Dalia Quwaider, Elizabeta A. Rojas, Rocío Corral, Luis Antonio Corchete, Ana A. Martin, MD, Fernando Escalante, Abelardo Bárez, Juan Luis Garcia, PhD, Isidro Sanchez-Garcia, MD PhD, Ramón García-Sanz, MD PhD, Jesus F. San Miguel, Norma Carmen Gutierrez, PhD MD

Blood (2014) 124 (21): 2001.

https://doi.org/10.1182/blood.V124.21.2001.2001

Published: 2014

Journal Articles

Value Of Serum Free Light Chains Ratio As New Biomarker Of High Prognostic Value In Patients With Newly Diagnosed Multiple Myeloma

José Luis García de Veas Silva, Carmen Bermudo, Stephen Harding, Rafael Duro Millán

Blood (2013) 122 (21): 1862.

https://doi.org/10.1182/blood.V122.21.1862.1862

Published: 2013

Journal Articles

Inter-Observer Discordance With The Diagnosis Of Myelodysplastic Syndromes With Less Than 5% Bone Marrow Blasts: Unilineage Vs Multilineage Dysplasia and Reproducibility Of The Threshold Of 2% Blasts

Patricia Font, Javier Loscertales, Carlos Soto, Pilar Ricard, Carolina Muñoz Novas, Estela Martin-Clavero, Montserrat Lopez-Rubio, Luis Garcia-Alonso, Marta Callejas, Alfredo Bermejo, Celina Benavente, Monica Ballesteros, Teresa Cedena, María Calbacho, Raquel Urbina, Jesus Villarrubia, Ana Villegas

Blood (2013) 122 (21): 2768.

https://doi.org/10.1182/blood.V122.21.2768.2768

Published: 2013

Journal Articles

FLT3, PIM and CXCR4 Expression In Acute Myeloid Leukemia

Rafael Alonso Fernández, Inmaculada Rapado, MD, Castro Nerea, MD, Pilar Martinez-Sanchez, MD, Ascensión Peña, MD, Luis Garcia-Alonso, MD, Montserrat Rubio, MD, Antonia Rodriguez, MD, Maria del Pilar Martinez-Barranco, MD, Maria del Carmen Calle, MD, Maria Jose Otero, MD, Juan Carlos Ponce, Florinda Gilsanz-Rodriguez, Rosa M. Ayala, MD, PhD, Joaquin Martinez-Lopez, MD, PhD

Blood (2013) 122 (21): 4957.

https://doi.org/10.1182/blood.V122.21.4957.4957

Published: 2013

Journal Articles

Clinical and Biological Characterization of Patients with Low/Intermediate-1 Risk Myelodysplastic Syndrome and Iron Overload

Blood (2012) 120 (21): 4956.

https://doi.org/10.1182/blood.V120.21.4956.4956

Published: 2012

Journal Articles

HGAL-a Germinal Center Specific Protein, Enhances B-Cell Receptor Signaling by Activation of Syk, Leading to Follicular Lymphoproliferation

Xiaoyu Jiang, PhD, Isabel Romero-Camarero, Ph.D, Xiaoqing Lu, M.D, Carolina Vicente-Dueñas, Ines Gonzalez-Herrero, Teresa Flores, Juan Luis Garcia, George McNamara, Ph.D, Christian Kunder, Yasodha Natkunam, MD, PhD, Victor Segura, PhD, Lorenna Fontan-Gabas, Jose A Martinez-Climent, MD, PhD, Ash A Alizadeh, MD/PhD, Cesar Cobaleda, PhD, Isidro Sanchez-Garcia, MD, Izidore S Lossos, MD

Blood (2011) 118 (21): 584.

https://doi.org/10.1182/blood.V118.21.584.584

Published: 2011

NARROW

Plasmablastic Lymphoma: Experience from a Single Referral Center in Mexico

Interobserver Variability with the Diagnosis of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) ¿Is the Threshold of 20% Bone Marrow Blasts Reproducible?

The Elevation of LIVER Enzymes in Patients with Atrial Fibrillation and COVID-19 Is a Marker of Bad Evolution and Mortality

Blood monitoring of circulating tumor plasma cells by next generation flow in multiple myeloma after therapy

Altered Immunophenotypes on Leukemic and/or Monocytic Cells from Acute Myeloid Leukemia Highly Predict for Nucleophosmin Gene Mutation

CRISPR/Cas9-Generated Models Uncover Therapeutic Vulnerabilities of Del(11q) Chronic Lymphocytic Leukemia Cells to Dual BCR and PARP Inhibition

Multiparametric Flow Fytometry Is More Useful Than Cytology As a Diagnostic Tool for Endoscopic and Transbronchial Ultrasound-Guided Fine Needle Aspiration Samples in Hematological Malignancies: A Single Center Experience

Sustained Overall Survival Benefit with Lenalidomide Plus Dexamethasone Versus No Treatment in Patients with Smoldering Myeloma at High Risk of Progression to Myeloma: Long Term Analysis

Hemorrhagic Cystitis in Haploidentical Hematopoietic STEM CELL Trasplant: Retrospective Study and Comparison with a NON-Haploidentical DONOR Transplant Group

Immunoglobulin Heavy/Light Chain Ratio and Suppression of the Myeloma Non-Involved Heavy/Light Chain Pair Isotype Correlate with Poor Survival in Multiple Myeloma at Diagnosis and after Autologous Stem Cell Transplant

Prognostic Impact, Phenotypic and Molecular Characterization of Concordant and Discordant Bone Marrow Involvement in Patients with Diffuse Large b-Cell Lymphoma

Multiple Myeloma with Prior Precursor Disease Shows Better Outcome

A New Model for Risk Stratification in Patients with Newly Diagnosed Multiple Myeloma: Impact of Serum Free Light Chains in Prognosis

Long Term Follow-up on the Tretament of High Risk Smoldering Myeloma with Lenalidomide Plus Low Dose Dex (Rd) (phase III spanish trial): Persistent Benefit in Overall Survival

Post-Transcriptional Modifications Explain the Overexpression of CCND2 in Multiple Myeloma

Value Of Serum Free Light Chains Ratio As New Biomarker Of High Prognostic Value In Patients With Newly Diagnosed Multiple Myeloma

Inter-Observer Discordance With The Diagnosis Of Myelodysplastic Syndromes With Less Than 5% Bone Marrow Blasts: Unilineage Vs Multilineage Dysplasia and Reproducibility Of The Threshold Of 2% Blasts

FLT3, PIM and CXCR4 Expression In Acute Myeloid Leukemia

Clinical and Biological Characterization of Patients with Low/Intermediate-1 Risk Myelodysplastic Syndrome and Iron Overload

HGAL-a Germinal Center Specific Protein, Enhances B-Cell Receptor Signaling by Activation of Syk, Leading to Follicular Lymphoproliferation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only